The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine
Keywords: واکسن مالاریا; Adjuvants; Immunomodulators; B7-1; B7-2; CD80; CD86; Co-stimulatory molecules; ICAM-1; CD54; Intercellular adhesion molecule 1; Plasmodium falciparum; Malaria vaccine; Merozoite surface protein 1; MSP1